Literature DB >> 2157899

Alpha/beta interferons fail to induce antiviral activity from within the nucleus.

I Riviere1, J de Maeyer-Guignard.   

Abstract

Electrophoretically pure murine alpha/beta interferons (IFN-alpha/beta) were microinjected directly into the nuclei of mouse L cells, each nucleus receiving 10 fl containing about 20,000 (IFN) molecules, an amount sufficient to induce the antiviral state when added to the culture medium of control cells. Three, six or 24 h after intranuclear delivery, the cells were challenged with vesicular stomatitis virus or Semliki Forest virus and the appearance of cytopathic effects was scored for each individual cell. The scoring of more than 1,000 intranuclearly injected cells in nine different experiments showed unambiguously that the intranuclear delivery of IFN-alpha/beta did not induce the antiviral state. The results argue strongly against the physiological importance of high-affinity nuclear binding sites for native IFN that have been recently described (V. M. Kushnaryov, H. S. MacDonald, G. P. Lemense, J. Debruin, J. J. Sedmak, and S. E. Grossberg, Cytobios 53:185-197, 1988). Together with earlier results of other groups describing the lack of IFN activity after intracytoplasmic injection (Y. Higashi and Y. Sokawa, J. Biochem. 91:2021-2028, 1982; G. Huez, M. Silhol, and B. Lebleu, Biochem. Biophys. Res. Commun. 110:155-160, 1983), these results lend weight to the hypothesis that the binding of IFN-alpha/beta to the plasma membrane receptor is sufficient to set into motion the complex mechanism of transmembrane signalling without requiring internalization of the bound IFN molecules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157899      PMCID: PMC249410          DOI: 10.1128/JVI.64.5.2430-2432.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells.

Authors:  R L Friedman; S P Manly; M McMahon; I M Kerr; G R Stark
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

2.  Microinjection of tissue culture cells.

Authors:  M Graessmann; A Graessmann
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Delayed hypersensitivity to Newcastle disease virus in high and low interferon-producing mice.

Authors:  E De Maeyer; J De Maeyer-Guignard
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

4.  Ultrastructural distribution of interferon receptor sites on mouse L fibroblasts grown in suspension: ganglioside blockade of ligand binding.

Authors:  V M Kushnaryov; H S MacDonald; J J Sedmak; S E Grossberg
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns.

Authors:  J De Maeyer-Guignard; M G Tovey; I Gresser; E De Maeyer
Journal:  Nature       Date:  1978-02-16       Impact factor: 49.962

6.  Microinjection of anti-interferon antibodies into cells does not inhibit the induction of an antiviral state by interferon.

Authors:  H Arnheiter; K C Zoon
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Microinjection of interferon and 2',5'-oligoadenylate into mouse L cells and their effects on virus growth.

Authors:  Y Higashi; Y Sokawa
Journal:  J Biochem       Date:  1982-06       Impact factor: 3.387

8.  Automatic microinjection system facilitates detection of growth inhibitory mRNA.

Authors:  R Pepperkok; M Zanetti; R King; D Delia; W Ansorge; L Philipson; C Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Human interferon alpha enters cells by receptor-mediated endocytosis.

Authors:  K C Zoon; H Arnheiter; D Zur Nedden; D J Fitzgerald; M C Willingham
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

10.  Microinjected interferon does not promote an antiviral response in Hela cells.

Authors:  G Huez; M Silhol; B Lebleu
Journal:  Biochem Biophys Res Commun       Date:  1983-01-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.